Other OTC - Delayed Quote USD

Fresh Tracks Therapeutics, Inc. (FRTX)

0.9101 -0.0105 (-1.14%)
At close: April 26 at 1:02 PM EDT
Key Events
Loading Chart for FRTX
DELL
  • Previous Close 0.9206
  • Open 0.9101
  • Bid --
  • Ask --
  • Day's Range 0.9101 - 0.9206
  • 52 Week Range 0.4500 - 1.1000
  • Volume 795
  • Avg. Volume 14,396
  • Market Cap (intraday) 5.436M
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0600
  • Earnings Date May 8, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

ir.frtx.com

4

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FRTX

Performance Overview: FRTX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FRTX
3.42%
S&P 500
6.92%

1-Year Return

FRTX
49.20%
S&P 500
25.26%

3-Year Return

FRTX
97.83%
S&P 500
22.00%

5-Year Return

FRTX
99.76%
S&P 500
74.29%

Compare To: FRTX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FRTX

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    5.44M

  • Enterprise Value

    -3.49M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.61

  • Price/Book (mrq)

    0.55

  • Enterprise Value/Revenue

    -0.44

  • Enterprise Value/EBITDA

    0.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -71.12%

  • Return on Assets (ttm)

    -36.37%

  • Return on Equity (ttm)

    -66.50%

  • Revenue (ttm)

    8.01M

  • Net Income Avi to Common (ttm)

    -5.69M

  • Diluted EPS (ttm)

    -1.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.87M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.67M

Research Analysis: FRTX

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: FRTX

Fair Value

0.9101 Current
 

Dividend Score

0 Low
FRTX
Sector Avg.
100 High
 

Hiring Score

0 Low
FRTX
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
FRTX
Sector Avg.
100 High
 

Research Reports: FRTX

  • Daily – Vickers Top Buyers & Sellers for 04/02/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 01/18/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 01/12/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 01/08/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch